315 related articles for article (PubMed ID: 32228575)
1. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
[TBL] [Abstract][Full Text] [Related]
2. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
[TBL] [Abstract][Full Text] [Related]
3. First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency.
Cai MT; Lai QL; Zheng Y; Fang GL; Shen CH; Xu YF; Zhang YX; Ding MP
Mult Scler Relat Disord; 2022 Oct; 66():104071. PubMed ID: 35917744
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: a case series.
Incecik F; Herguner OM; Besen S; Yılmaz M
Acta Neurol Belg; 2018 Sep; 118(3):411-414. PubMed ID: 29349679
[TBL] [Abstract][Full Text] [Related]
5. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
[TBL] [Abstract][Full Text] [Related]
6. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
[No Abstract] [Full Text] [Related]
7. Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations.
Hao W; Davis C; Daniels T; Hampe CS; Lernmark A
Transfus Med; 1999 Dec; 9(4):307-10. PubMed ID: 10583884
[TBL] [Abstract][Full Text] [Related]
8. Anti-GAD65 Antibody-Associated Autoimmune Encephalitis With Predominant Cerebellar Involvement Following Toripalimab Treatment: A Case Report of a Novel irAE of Toripalimab.
Zhou H; Xie X; Zhang T; Yang M; Zhou D; Yang T
Front Immunol; 2022; 13():850540. PubMed ID: 35401563
[TBL] [Abstract][Full Text] [Related]
9. Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.
Muñoz-Lopetegi A; de Bruijn MAAM; Boukhrissi S; Bastiaansen AEM; Nagtzaam MMP; Hulsenboom ESP; Boon AJW; Neuteboom RF; de Vries JM; Sillevis Smitt PAE; Schreurs MWJ; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123047
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort.
Douma B; Ben Younes T; Benrhouma H; Miladi Z; Zamali I; Rouissi A; Klaa H; Kraoua I; Ben Ahmed M; Ben Youssef Turki I
J Immunol Res; 2021; 2021():6666117. PubMed ID: 34056010
[TBL] [Abstract][Full Text] [Related]
11. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
12. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of autoimmune encephalitis patients associated with anti-glutamate decarboxylase antibody 65.
Zhang YF; Yu N; Lin XJ; Wang L; Shi J; Zhang QQ; Di Q
Clin Neurol Neurosurg; 2020 Sep; 196():106082. PubMed ID: 32682224
[TBL] [Abstract][Full Text] [Related]
14. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Cavaletti G; Giannini F; Sabatelli M; Beghi E;
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):729-34. PubMed ID: 25246645
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis.
Gong X; Luo R; Liu J; Guo K; Li A; Liu X; Liu Y; Zhou D; Hong Z
Eur J Neurol; 2022 Apr; 29(4):1117-1127. PubMed ID: 34918418
[TBL] [Abstract][Full Text] [Related]
17. Multiple co-existing antibodies in autoimmune encephalitis: A case and review of the literature.
Kammeyer R; Piquet AL
J Neuroimmunol; 2019 Dec; 337():577084. PubMed ID: 31655424
[TBL] [Abstract][Full Text] [Related]
18. Stiff-Person Syndrome Associated with Anti-Glutamic Acid Decarboxylase Autoimmune Encephalitis in a Young Woman: A Case Report.
Gao SY; Lu J; Zhao CB
Chin Med Sci J; 2020 Dec; 35(4):387-390. PubMed ID: 33413757
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
[TBL] [Abstract][Full Text] [Related]
20. Opercular myoclonic-anarthric status epilepticus due to glutamic acid decarboxylase antibody-associated encephalitis.
Monnerat BZ; Velasco TR; Nakano FN; Júnior AV; Martins AP; Sakamoto AC
Epileptic Disord; 2013 Sep; 15(3):342-6. PubMed ID: 23981587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
